Galbraith Kenneth

Chair & CEO at ZYME; Director at MGNX

Sold, on record
$5M
Dollars the filings state
Form 4 sales
6
Latest Jan 12, 2026
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • ZYMEZymeworks Inc.Chair & CEO
  • MGNXMACROGENICS INCDirector

Sales by reason

0
Routine
0
Plan not stated
2
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale MGNXUnusual
    Sep 9 2020

    Sold 20,773 shares at $27.11 ($563k)

    Galbraith Kenneth, Director

    Sold 100% of holdings ($563k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice ZYMENotice
    Jan 5 +1213 days

    Filed to sell 23,904 shares ($252k)

    Galbraith Kenneth, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale ZYMEUnusual
    Jan 8 +3 days

    Sold 23,904 shares at $10.79 ($258k)

    Galbraith Kenneth, Chair & CEO

    No 10b5-1 planSold 50.1% of holdings ($514k position)23,762 shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 4 sale ZYMEUnusual
    Jan 6 +364 days

    Sold 57,291 shares at $14.92 ($855k)

    Galbraith Kenneth, Chair & CEO

    No 10b5-1 planSold 41.5% of holdings ($2.1M position)80,803 shares leftFiling

  5. 5 Form 4 sale ZYMEUnusual
    Dec 22 +350 days

    Sold 47,528 shares at $27.02 ($1.3M)

    Galbraith Kenneth, Chair & CEO

    No 10b5-1 planSold 26.3% of holdings ($4.9M position)133,275 shares leftFiling

  6. 6 Form 4 sale ZYMENo plan
    Jan 5 +14 days

    Sold 54,343 shares at $25.10 ($1.4M)

    Galbraith Kenneth, Chair & CEO

    No 10b5-1 planSold 21.9% of holdings ($6.2M position)193,266 shares leftFiling

  7. 7 Form 4 sale ZYMENo plan
    Jan 12 +7 days

    Sold 30,424 shares at $22.67 ($690k)

    Galbraith Kenneth, Chair & CEO

    No 10b5-1 planSold 11.8% of holdings ($5.8M position)226,842 shares left0.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Galbraith Kenneth
Source
Jan 12, 2026ZYMEChair & CEOForm 4 sale30,424$690k11.8%No planSEC
Jan 5, 2026ZYMEChair & CEOForm 4 sale54,343$1.4M21.9%No planSEC
Dec 22, 2025ZYMEChair & CEOForm 4 sale47,528$1.3M26.3%UnusualSEC
Jan 6, 2025ZYMEChair & CEOForm 4 sale57,291$855k41.5%UnusualSEC
Jan 8, 2024ZYMEChair & CEOForm 4 sale23,904$258k50.1%UnusualSEC
Jan 5, 2024ZYMEOfficer, DirectorForm 144 notice23,904$252kNoticeSEC
Sep 9, 2020MGNXDirectorForm 4 sale20,773$563k100.0%UnusualSEC